CORT
Corcept Therapeutics Incorporated
Stock
$116.23+2.20 (+1.93%)Close Oct 2, 2026
- Selling, general and administrative, 2025
- $449M
- YoY, 2025
- +60.1%
- 5-year CAGR
- +33.6%
- 10-year CAGR
- +28.4%
Selling, general and administrative
Selling, general and administrative by fiscal year
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $449M | +60.1% |
| 2024 | $280M | +52.1% |
| 2023 | $184M | +20.6% |
| 2022 | $153M | +24.9% |
| 2021 | $122M | +16.2% |
| 2020 | $105M | +4.9% |
| 2019 | $100M | +23.5% |
| 2018 | $81M | +30.2% |
| 2017 | $62M | +38.0% |
| 2016 | $45M | +22.4% |
| 2015 | $37M | +5.8% |
| 2014 | $35M | +11.8% |
| 2013 | $31M | +22.9% |
| 2012 | $25M | +124.3% |
| 2011 | $11M | +33.5% |
| 2010 | $8.5M | — |